Findings indicate that parental-cell passage and vesicle integrity influence the biological activity of hUC-MSC-derived exosomes and highlight the importance of standardized MSC characterization, passage control, and exosome quality assessment for the development of reproducible neuroregenerative products.
Abstract
Mesenchymal stem cell (MSC)-derived exosomes are promising mediators of neuroregeneration, but their functional heterogeneity remains incompletely understood. We investigated whether parental-cell passage and vesicle integrity influence the characteristics and biological activity of exosomes derived from human umbilical cord-derived MSCs (hUC-MSCs). hUC-MSC identity was confirmed by spindle-shaped morphology and flow cytometric analysis demonstrating high expression of CD73, CD90, and CD105 together with minimal expression of CD34 and CD45. Exosomes isolated from passages 1 (P1), 3 (P3), and 5 (P5) were characterized by nanoparticle tracking analysis (NTA), fluorescence NTA, scanning electron microscopy, and Western blotting. Their biological effects were evaluated in Neuro-2a (N2A) cells by immunofluorescence analysis of βIII-tubulin, MAP2, and NeuN together with the CCK-8 assay. P1-derived exosomes were associated with increases in neuronal-associated marker expression, neurite-like morphology, and CCK-8 metabolic activity, whereas heat-treated exosomes exhibited attenuated biological activity. These findings indicate that parental-cell passage and vesicle integrity influence the biological activity of hUC-MSC-derived exosomes and highlight the importance of standardized MSC characterization, passage control, and exosome quality assessment for the development of reproducible neuroregenerative products.
It is demonstrated that culture conditions substantially influence PMSC and EV properties and highlight the therapeutic potential of PMSC-EVs for translational development.
David Wang, Kaitlin Clark, Blaine Baker et al.· npj Regenerative Medicine· 0 citations
The dual-luciferase reporter gene assay confirmed the targeting linkage between miR-21 and JAG1, indicating that changes in miR-21 levels in hDPSCs impacted the expression of the JAG1/NOTCH1/VEGF signalling pathway.
Pei-Hui Li, Shuang Zhang, Wei-Wei Zhang et al.· International Dental Journal· 0 citations
BACKGROUND
Ischemic stroke is a leading cause of disability and mortality worldwide, with limited therapeutic options for long-term recovery. Bone marrow-derived mesenchymal stem cell (BMSC)-derived exosomes have emerged as a promising cell-free therapy, but their efficacy is often constrained by poor homing efficiency...
The results characterize the biological activity of a single UC-MSC-EVs preparation across multiple skin-related experimental systems and provide a basis for further investigation of its bioactive components and dose-response relationships.
Pei-Jun Zhao, Dan Xiao, Jing-Yu Xu et al.· Frontiers in Bioengineering...· 0 citations
Cell-free therapies based on the mesenchymal stem cells (MSCs) secretome are being widely explored for spinal cord injury (SCI). Induced pluripotent stem cells (iPSCs) provide a scalable source for generating mesenchymal stem cells (iMSCs), but limited studies have evaluated the modulatory capacity of iMSCs for CNS app...
João Afonso, Ana T. Palha, Marta F. Lima et al.· Biomolecules· 0 citations
Age-related degeneration remains a premier biomedical challenge, frequently underpinned by cellular senescence and stem cell dysfunction. Accumulating evidence suggests that umbilical cord mesenchymal stromal cell (UC-MSC)-derived extracellular vesicles (UC-EVs) and the longevity protein Klotho hold great promise as an...
An-Yuan Zhang, Shan Wang, Jing Zhang et al.· International Journal of Mol...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.